亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台，協助業界發掘知識產權貿易商機，並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權，或是製造商需要購買技術以提高操作效能，又或是知識產權配套服務供應商，你將會從本網站發掘到有用的知識產權貿易資訊。

返回搜索結果

PicoRNAVirus and Uses Thereof

總結: Lead Inventors: Ian LipkinProblem or Unmet Need:Respiratory tract infections may result in a wide spectrum of disease that ranges from minor discomfort to exacerbations of asthma and COPD/emphysema to acute fatal respiratory failure. During an investigation of Influenza-like illness (ILI) using methods that enable molecular detection and discovery of both cultivatable and non-cultivatable microbes, we discovered a novel picornavirus that was subsequently classified by the International Committee for Taxonomy of Viruses as the prototype of a new clade of picornaviruses (rhinovirus C) and determined to be globally distributed in association with significant pulmonary disease.This technology is directed to address a group of picornaviruses (rhinovirus C) associated with respiratory infection. This invention encompasses: Isolated nucleic acid sequences Peptides associated with isolated nucleic acid sequences Interfering RNA (iRNA) directed against relevant sequences Antibodies against relevant peptidesThis technology can be used to detect the presence or absence of the virus in a subject. The iRNA described in this invention could be used as therapeutic agents to lower viral titers in patients. This invention also describes methods for inducing an immune response against the virus in a subject.

技術優勢: Detects the novel virus Offers rapid and specific detection of the virus Treatment in the form of a specific iRNA can be tailored to the diagnosis Offers a method of vaccination such that a specific immune response against the virus can be inducedOpportunities: Assay for amplification and detection of virus Assay for detection of an immune response against the virus Development of vaccination against the virus Development of iRNA based therapeutic agent for reducing the vira titer

技術應用: Differential diagnosis of respiratory tract infection and detection of the virus Vaccines to prevent infection and disease due to the virus Therapeutic agents to prevent or ameliorate disease due to the virus

詳細技術說明: This technology is directed to address a group of picornaviruses (rhinovirus C) associated with respiratory infection. This invention encompasses: Isolated nucleic acid sequences Peptides associated with isolated nucleic acid sequences

*Inquiry: Ron Katz Columbia Technology Ventures Tel: (212) 854-8444 Email: TechTransfer@columbia.edu

*Publications: - J Infect Dis. 2007 Dec 15;196(12):1754-60. A recently identified rhinovirus genotype is associated with severe respiratory-tract infection in children in Germany.- J Infect Dis. 2006 Nov 15;194(10):1398-402. Epub 2006 Oct 6. MassTag polymerase-chain-reaction detection of respiratory pathogens, including a new rhinovirus genotype, that caused influenza-like illness in New York State during 2004-2005.

欲了解更多信息，請點擊這裡